We offer solutions including water-based lubricants, vaginal moisturizers, and, when appropriate, low-dose vaginal estrogen therapy to help improve vaginal tissue health and comfort
Apart from the standard pharmacovigilance and RMP update requirements, the TGA uses an enhanced post-market monitoring and compliance framework, and prioritises provisionally approved medicines for post-market surveillance activities
Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist December 18, 2024 6:45 am EST RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist
is here to provide legal guidance and support to people whove been adversely affected by taking Wegovy and similar GLP-1 drugs as directed